Ipilimumab vs Pravastatin
Ipilimumab vs Pravastatin: Overview
This comparison examines the pharmacological differences between Ipilimumab and Pravastatin.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pravastatin: Competitive inhibitor of HMG-CoA reductase.
Pharmacokinetics
Half-life: Ipilimumab β 14.7 days; Pravastatin β 1.8 hours.
Chemical Properties
Molecular Formula: Pravastatin β C23H36O7.
Molecular Weight: Pravastatin β 424.5280 g/mol.
Type: Ipilimumab β Antibody; Pravastatin β Small molecule.